Until then, it's available only through clinical trial enrollment (free, pharmaceutical-grade, medically supervised), compounding pharmacies ($200$500/month with prescription), or research peptide vendors ($150$500/month, grey market)
Evidence comparison: GHK-Cu has a substantially larger body of published research, spanning from Pickart's original 1973 isolation through hundreds of subsequent studies
It results in notable product loss that scales with the length of the peptide being synthesized
It only takes a few minutes and helps determine eligibility
If practicing good sleep hygiene does not improve symptoms of insomnia while on a GLP-1 receptor agonist, its a good idea to talk to your doctor
[1] Semaglutide has a half-life of approximately one week and is primarily eliminated through protein degradation